Comparison of the osteogenic potential of equine mesenchymal stem cells from bone marrow, adipose tissue, umbilical cord blood, and umbilical cord tissue

To determine the optimal osteogenic source of equine mesenchymal stem cells (eMSCs) and optimize collection of and expansion conditions for those cells. 10 adult Quarter Horses and 8 newborn Thoroughbred foals. eMSCs were isolated from bone marrow (BM), adipose tissue, and umbilical cord blood and t...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of veterinary research Vol. 71; no. 10; pp. 1237 - 1245
Main Authors Toupadakis, Chrisoula A, Wong, Alice, Genetos, Damian C, Cheung, Whitney K, Borjesson, Dori L, Ferraro, Gregory L, Galuppo, Lawrence D, Leach, J. Kent, Owens, Sean D, Yellowley, Clare E
Format Journal Article
LanguageEnglish
Published United States 01.10.2010
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:To determine the optimal osteogenic source of equine mesenchymal stem cells (eMSCs) and optimize collection of and expansion conditions for those cells. 10 adult Quarter Horses and 8 newborn Thoroughbred foals. eMSCs were isolated from bone marrow (BM), adipose tissue, and umbilical cord blood and tissue, and the osteogenic potential of each type was assessed. Effects of anatomic site, aspiration volume, and serum type on eMSC yield from BM were investigated. BM-eMSCs had the highest overall expression of the osteogenic genes Cbfa1, Osx, and Omd and staining for ALP activity and calcium deposition. There was no significant difference in BM-eMSC yield from the tuber coxae or sternum, but yield was significantly greater from the first 60-mL aspirate than from subsequent aspirates. The BM-eMSC expansion rate was significantly higher when cells were cultured in fetal bovine serum instead of autologous serum (AS). eMSCs from BM possessed the highest in vitro osteogenic potential; eMSCs from adipose tissue also had robust osteogenic potential. The tuber coxae and the sternum were viable sources of BM-eMSCs in yearlings, and 60 mL of BM aspirate was sufficient for culture and expansion. Expanding BM-eMSCs in AS to avoid potential immunologic reactions decreased the total yield because BM-eMSCs grew significantly slower in AS than in fetal bovine serum. Additional studies are needed to determine optimal ex vivo eMSC culture and expansion conditions, including the timing and use of growth factor—supplemented AS.
ISSN:0002-9645
1943-5681
DOI:10.2460/ajvr.71.10.1237